Patents by Inventor Raphaëlle Bourdet-Sicard

Raphaëlle Bourdet-Sicard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LACTOCOCCUS LACTIS FOR USE IN PREVENTING OR TREATING MINERAL DEFICIENCY
    Publication number: 20230200422
    Abstract: The present invention relates to the use of Lactococcus lactis suitable for preventing or treating mineral deficiency or insufficiency by increasing the bioavailability of phytate bound minerals. The present invention provides novel strains, compositions comprising said strains and methods for the preparation of such compositions.
    Type: Application
    Filed: May 25, 2020
    Publication date: June 29, 2023
    Inventors: Audrey BONIFACE-GUIRAUD, Jean-Michel FAURIE, Raphaëlle BOURDET-SICARD
  • Reuterin-producing
    Patent number: 9387229
    Abstract: The invention relates to reuterin-producing strains of Lactobacillus brevis. These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: July 12, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard
  • Strain of capable of inhibiting the adhesion of strains to epithelial cells
    Patent number: 9272007
    Abstract: The present invention relates to a new strain of Lactobacillus delbrueckii subsp. bulgaricus, suitable for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: March 1, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard, Francis Megraud
  • STREPTOCOCCUS THERMOPHILUS STRAINS FOR TREATING HELICOBACTER PYLORI INFECTION
    Publication number: 20150284675
    Abstract: The present invention relates to a strain of Streptococcus thermophilus or a cell fraction thereof for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Application
    Filed: October 25, 2012
    Publication date: October 8, 2015
    Inventors: Peggy Garault, Raphaelle Bourdet-Sicard, Francis Megroud
  • with anti-oxidant action
    Patent number: 9056123
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: June 16, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Reuterin-Producing Lactobacillus Brevis
    Publication number: 20140341855
    Abstract: The invention relates to reuterin-producing strains of Lactobacillus brevis. These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
    Type: Application
    Filed: November 30, 2011
    Publication date: November 20, 2014
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard
  • Strain of L. Bulgaricus Capable of Inhibiting the Adhesion of H. Pylori Strains to Epithelial Cells
    Publication number: 20140205571
    Abstract: The present invention relates to a new strain of Lactobacillus delbrueckii subsp. bulgaricus, suitable for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Application
    Filed: August 9, 2011
    Publication date: July 24, 2014
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard, Francis Megraud
  • Method for selecting bacteria with anti-oxidant action
    Patent number: 8735089
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: May 27, 2014
    Assignees: Compagnie Gervais Danone, Biopolis S.L.
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Lactobacilli with Anti-Oxidant Action
    Publication number: 20130171117
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 4, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Method for Selecting Bacteria with Anti-Oxidant Action
    Publication number: 20130078187
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Application
    Filed: January 8, 2010
    Publication date: March 28, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Use of for increasing the protection provided by the influenza vaccine
    Patent number: 8349315
    Abstract: The invention relates to the use of Lactobacillus casei in orally administrable compositions for increasing protection against influenza after the influenza vaccine, by potentiating the humoral response generated by said vaccine.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: January 8, 2013
    Assignee: Compagnie Gervais Danone
    Inventors: Sandrine Samson-Villeger, Raphaëlle Bourdet-Sicard
  • Use of a fermented milk containing for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
    Patent number: 8309074
    Abstract: The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, Lactobacillus casei CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: November 13, 2012
    Assignee: Compagnie Gervais Danone
    Inventors: Jean François Nicolas, Catherine Goujon, Raphaëlle Bourdet-Sicard, Nathalie Rolf-Pedersen
  • Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation
    Publication number: 20100284973
    Abstract: The present invention pertains to the field of prevention and treatment of chronic or acute diseases involving mast cells, such as allergy and some autoimmune diseases. More precisely, the present invention concerns the use of probiotics containing a L. casei strain and/or a B. breve strain for inhibiting mast cell activation. The present invention relates also to screening processes for identifying bacterial strains which can be used for preparing said probiotics.
    Type: Application
    Filed: December 1, 2008
    Publication date: November 11, 2010
    Inventors: Cécile Schiffer-Mannioui, Mare Daëron, Sandrine Samson, Raphaëlle Bourdet-Sicard
  • Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine
    Publication number: 20100129334
    Abstract: The invention relates to the use of Lactobacillus casei in orally administrable compositions for increasing protection against influenza after the influenza vaccine, by potentiating the humoral response generated by said vaccine.
    Type: Application
    Filed: February 13, 2008
    Publication date: May 27, 2010
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sandrine Samson-Villeger, Raphaelle Bourdet-Sicard
  • Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction
    Publication number: 20090068149
    Abstract: The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, Lactobacillus casei CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
    Type: Application
    Filed: January 20, 2006
    Publication date: March 12, 2009
    Inventors: Jean Francois Nicolas, Catherine Goujon, Raphaelle Bourdet-Sicard, Nathalie Rolf-Pedersen